Biotechnology firm LianBio raised $325 million in an initial public offering, according to astatement, potentially opening a narrow path for U.S. listings by companies operating primarily in China. ...
网页链接Biotechnology firm LianBio raised $325 million in an initial public offering, according to astatement, potentially opening a narrow path for U.S. listings by companies operating primarily in China. ...
网页链接
精彩评论